Agree, just look at the top shareholders and the background of the board, you won't get that sort of backing and technical knowhow very often. With positive results in the clinical trials i believe it should surge towards 100m market cap, massive potential and very limited downside when one considers all the potential applications.
for me it's a no brainer long term hold, keep accumulating at support levels and wait for the positive announcements to come.
Ann: Quarterly Activities and Cashflow Reports - Dec 2020 Qtr, page-7
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
